Renal cancer: FDA reporting patterns
47,602 FDA FAERS reports mention Renal cancer. 47,052 reports have a serious outcome flag.
Medicines named as suspect
- Ranitidine: 40,794 reports
- Sunitinib: 578 reports
- Adalimumab: 377 reports
- Axitinib: 343 reports
- Valsartan: 295 reports
- Etanercept: 279 reports
- Pazopanib: 211 reports
- Infliximab: 194 reports
- Esomeprazole: 158 reports
- Everolimus: 156 reports
- Omeprazole: 149 reports
- Methotrexate: 129 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.